![Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0960977620301120-fx1.jpg)
Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect
![A prognostic model for colorectal cancer based on CEA and a 48-multiplex serum biomarker panel | Scientific Reports A prognostic model for colorectal cancer based on CEA and a 48-multiplex serum biomarker panel | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-80785-1/MediaObjects/41598_2020_80785_Fig1_HTML.png)
A prognostic model for colorectal cancer based on CEA and a 48-multiplex serum biomarker panel | Scientific Reports
![Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers | Semantic Scholar Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bf27a8f33dc1177ab0c7cf3c2adec21f5727b20d/3-Table1-1.png)
Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers | Semantic Scholar
![Case Report: CEA Elevation Can Be a Marker of Increased Inflammation During Treatment with Oxaliplatin | Anticancer Research Case Report: CEA Elevation Can Be a Marker of Increased Inflammation During Treatment with Oxaliplatin | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/38/3/1711/F1.large.jpg)
Case Report: CEA Elevation Can Be a Marker of Increased Inflammation During Treatment with Oxaliplatin | Anticancer Research
![Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screening | Scientific Reports Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screening | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-75319-8/MediaObjects/41598_2020_75319_Fig1_HTML.png)